Altered transcription factor trafficking in oxidatively-stressed neuronal cells.
Age-related neurodegenerative diseases are associated with alterations in gene expression in affected neurons. One of the mechanisms that could account for this is altered subcellular localization of transcription factors, which has been observed in human post-mortem brains of each of the major neurodegenerative diseases, including Parkinson's disease (PD). The specific mechanisms are yet to be elucidated; however a potential mechanism involves alterations in nuclear transport. In this study, we examined the nucleocytoplasmic trafficking of select transcription factors in response to a PD-relevant oxidative injury, 6-hydroxydopamine (6OHDA). Utilizing a well-established model of ligand-regulated nucleocytoplasmic shuttling, the glucocorticoid receptor, we found that 6OHDA selectively impaired nuclear import through an oxidative mechanism without affecting nuclear export or nuclear retention. Interestingly, impaired nuclear import was selective as Nrf2 (nuclear factor E2-related factor 2) nuclear localization remained intact in 6OHDA-treated cells. Thus, oxidative stress specifically impacts the subcellular localization of some but not all transcription factors, which is consistent with observations in post-mortem PD brains. Our data further implicate a role for altered microtubule dependent trafficking in the differential effects of 6OHDA on transcription factor import. Oxidative disruption of microtubule-dependent nuclear transport may contribute to selective declines in transcriptional responses of aging or diseased dopaminergic cells.
Department of Pathology, Division of Neuropathology, University of Pittsburgh, Pittsburgh, PA 15261, USA. vpp3@pitt.edu
Vivek P
VP
Patel
Donald B
DB
Defranco
Charleen T
CT
Chu
D021581:Active Transport, Cell Nucleus / Q000187:drug effects*; D045744:Cell Line, Tumor; D015870:Gene Expression / Q000187:drug effects; D006801:Humans; D051267:NF-E2-Related Factor 2 / Q000378:metabolism*; D009447:Neuroblastoma; D018384:Oxidative Stress; D016627:Oxidopamine / Q000494:pharmacology*; D010300:Parkinson Disease / Q000378:metabolism*; D011965:Receptors, Glucocorticoid / Q000378:metabolism*; D014404:Tubulin / Q000378:metabolism
D051267:NF-E2-Related Factor 2; C495635:NFE2L2 protein, human; D011965:Receptors, Glucocorticoid; D014404:Tubulin; D016627:Oxidopamine